Adjuvant Treatment of Colorectal Cancer. The European Experience

Aranda E. , Cervantes A. , Carrato A. : The Spanish experience with high-dose infusional 5-FU in colorectal cancer. J. Infus. Chemoth., 1996 (in press).

Beerblock K. , Rinaldi I. , André T. , Gangré J.D. , Louvert C. , Tournigand C. , Carola E. , Favre R. , Krulek M. , de Gramont A. : Bi-weekly high-dose folinic acid (FA) and 5-fluorouracil (5FU) 48-h infusion in metastatic colorectal cancer. Proc. Am. Soc. Clin. Oncol., 15: 212, 1996.

Cedermark B. , Johansson H. , Rutqvist E. , Wilking N. : The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Cancer, 75: 2269–2275, 1995.

de Gramont A. , Bosset J.F. , Milan C. , Rougier P. , Bouché O. , Etienne P.L. , Morran F. , Louvet C. , Guillot T. , Bedenne L. : A prospectively randomized trial comparing 5FU bolus with low dose folinic acid (FUFOLld) and 5FU bolus plus continuous infusion with high dose folinic acid (LV5FU2) for advanced colorectal cancer. Proc. Am. Soc. Clin. Oncol., 14: 194 (abstr), 1995.

Díaz-Rubio E. , Aranda E. , Camps M.D. , Fernandez-Martos C. , Carrato A. , Anton A. , Cervantes A. , Tres A. , Fonseca E. , Belén J. , Gonzalo-Mancha R. , Dominiguez S. , Sánchez J.J. : A phase II study of weekly 48-hour infusions with high-dose fluorouracil in advanced colorectal cancer. An alternative to biochemical modulation. J. Infusional Chemoth. 4: 58–61, 1994.

Francini G. , Petrioli R. , Marsili S. , Aquino A. , Lorenzini L. , Mancini S. , Mazocca G. , Lorenzi M. , Arminio S. , Tanzini G. , Civitelli S. , Mariani L. , De Santo D. , Bovenga S. : Folinic acid plus 5-fluorouracil as adjuvant chemotherapy in colon cancer. Proc. Am. Soc. Clin. Oncol., 13: 196, 1994.

Gérard A. , Buyse M. , Nordlinger B. : Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann. Surg., 208: 606–614, 1988.

International multicentre pooled analysis of colon cancer trials (impact) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet, 345: 939–944, 1995.

Köhne C.H. , Schöffski P. , Wilke H. , Käufer C. , Rauschecker H. , Andreesen R. , Ohl U. , Lange H.J. , Klaassen U. , Westerhausen M. , Hiddemann W. , Schott G. , Bade J. , Strohmeyer G. , Schubert U. , Hecker H. , Schmoll H. : Modulation of weekly high dose infusional 5-fluorouracil (FU) by leucovorin (LV), alpha-interferon (IFN) or LV plus IFN in advanced colorectal cancer. Results of a multicenter randomized trial of the AIO. Eur. J. Cancer, 31a, suppl 5: 153, 1995.

Köhne C.H. , Wilke H. , Hecker H. , Schöffski P. , Käufer C. , Rouschecker H. , Andreesen R. , Ohl U. , Lange H.J. , Klaassen U. , Westerhausen M. , Hiddemann W. , Hennemann B. , Schott G. , Bade J. , Strohmeyer G. , Harstrick A. , Schubert U. , Bokemeyer C. , Schmoll H.J. : Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO). Ann. Oncol., 6: 461–466, 1995.

O'Connell M.J. , Martenson J.A. , Wieand H.S. , Krook J.E. , Macdonald J.S. , Haller D.G. , Mayer R.J. , Gunderson L.L. , Rich T.A. : Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med., 331: 502–507, 1994.

Piedbois P. , Buyse M. , Gray R. , Clarke M. , Wolmark N. , Metzger V. , Fielding L.P. , Gray B. , Taylor I. , Wereldsma J. , Ryan J. , Marsoni S. , Gruenagel H.H. for the Liver Infusion Meta-Analysis Project: Portal vein infusion is an effective adjuvant treatment for patients with colorectal cancer. Proc. Am. Soc. Clin. Oncol., 14: 192 (abstr), 1995.

Ryan J. , Weiden P. , Crowley J. , Block K. : Adjuvant portal vein infusion for colorectal cancer: a 3-arm randomized trial. Proc. Am. Soc. Clin. Oncol., 7: 95, 1988.

Sahmoud T. , Rougier P. , Nitti D. , Doci R. , De Woule B. , Nakajima T. , Rauschecker H. , Curran D. , Sakamoto J. , Labianca R. , Pecter J.C. , Marsoni S. , Torri V. , Bleiberg H. , Couvreni M.L. , Wils J. : Adjuvant portal vein infusion of 5-FU and heparin (PVI) in colorectal cancer: an EORTC-GIVIO Intergroup phase III trial. Ann. Oncol., 7(Suppl. 5): 33, 1996.

Swiss Group for Cancer Research (SAKK): Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet, 345: 349–353, 1995.

Wils J. : Adjuvant treatment of colorectal cancer in The Netherlands: a commentary. Neth. J. Med., 49: 52–53, 1996.

Wils J. , Bleiberg H. , Rougier P.H. : Adjuvant treatment of colon cancer. A plea for a large scale European trial. Eur. J. Cancer, 30A: 578–579, 1994.

Wils J.A. , Wagener D.J. Th. : Adjuvant treatment of colon cancer. Where to go from here? Ann. Oncol., 1: 329–331, 1990.

Wils J. , Wagener D.J. Th. : Combined modality adjuvant treatment of high-risk rectal cancer: a treatment of choice or a choice of treatment? Ann. Oncol., 3: 197–199, 1992.